Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential Stauber RH; Mann W; Knauer SKCancer Res 2007[Jul]; 67 (13): 5999-6002Survivin's proposed dual role as an apoptosis inhibitor and a mitotic effector positioned it in the front line of cancer research. Notably, survivin is detected as a cytoplasmic and nuclear protein in cancer patients, which stimulated numerous studies to investigate and to speculate on the functional and prognostic significance of its dynamic localization. Recent evidence shows that the direct interaction of survivin with the nuclear export receptor Crm1 is critically involved in its intracellular localization and cancer-relevant functions. Here, we review our current understanding of the Crm1/survivin interface and discuss its potential prognostic and therapeutic relevance.|*Gene Expression Regulation, Neoplastic[MESH]|Active Transport, Cell Nucleus[MESH]|Cell Nucleus/*metabolism[MESH]|Cytoplasm/*metabolism[MESH]|Exportin 1 Protein[MESH]|Humans[MESH]|Inhibitor of Apoptosis Proteins[MESH]|Karyopherins/physiology[MESH]|Microtubule-Associated Proteins/*biosynthesis[MESH]|Mitosis[MESH]|Models, Biological[MESH]|Neoplasm Proteins/*biosynthesis/metabolism[MESH]|Neoplasms/*diagnosis/*metabolism/pathology[MESH]|Prognosis[MESH]|Receptors, Cytoplasmic and Nuclear/physiology[MESH]|Survivin[MESH] |